Structure-Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion Synthesis
- Research Organization:
- Brookhaven National Lab. (BNL), Upton, NY (United States)
- Sponsoring Organization:
- ~OTHER
- DOE Contract Number:
- SC0012704
- OSTI ID:
- 1783738
- Report Number(s):
- BNL-221420-2021-JACI
- Journal Information:
- ChemMedChem, Vol. 16, Issue 7; ISSN 1860-7179
- Publisher:
- ChemPubSoc Europe
- Country of Publication:
- United States
- Language:
- English
Similar Records
Structure-Based Drug Design and Synthesis of PI3K[alpha]-Selective Inhibitor (PF-06843195)
Structure-Based Drug Design and Synthesis of PI3K[alpha]-Selective Inhibitor (PF-06843195)
Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design
Journal Article
·
2021
· J. Med. Chem.
·
OSTI ID:1808101
+36 more
Structure-Based Drug Design and Synthesis of PI3K[alpha]-Selective Inhibitor (PF-06843195)
Journal Article
·
2021
· J. Med. Chem.
·
OSTI ID:1810145
+36 more
Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design
Journal Article
·
2017
· Bioorganic and Medicinal Chemistry
·
OSTI ID:1549649
+16 more